Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors

NCT01118611 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Aurora B/C kinase inhibitor GSK1070916A
OTHER: laboratory biomarker analysis
OTHER: pharmacological study
PROCEDURE: diffusion-weighted magnetic resonance imaging + PET CT
RADIATION: fludeoxyglucose F 18 dynomic contrast

Sponsor

Cancer Research UK